22 November 2017
News and Views
Links and Services
Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett’s esophagus, reports April's issue of the Clinical Gastroenterology & Hepatology.
Obesity is associated with neoplasia, possibly via insulin-mediated cell pathways that affect cel
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors